(Q37103060)

18 August 2017

1 reference

title

M1 muscarinic agonists target major hallmarks of Alzheimer's disease--the pivotal role of brain M1 receptors (English)

1 reference

18 August 2017

0 references

Abraham Fisher

1

1 reference

18 August 2017

publication date

6 March 2008

1 reference

Neurodegenerative Diseases

18 August 2017

published in

1 reference

18 August 2017

volume

5

1 reference

18 August 2017

issue

3-4

1 reference

18 August 2017

page(s)

237-240

1 reference

M1 receptors play a central role in modulating AD-like pathology in transgenic mice

18 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1159%2F000113712

Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1159%2F000113712

alpha- and beta-secretase: profound changes in Alzheimer's disease.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1159%2F000113712

21 January 2018

Identifiers

DOI

10.1159/000113712

1 reference

release_yvvwaqxlbba73l7uxdxwnbrdte

18 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yvvwaqxlbba73l7uxdxwnbrdte

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference